AI assistant
va-Q-tec AG Earnings Release 2020
459_ip_2020-05-11_225fd2b1-d26b-444d-a804-b16ac7e4923e.pdf
Earnings Release
Open in viewerOpens in your device viewer
va-Q-tec AG Q1 2020 Earnings Release
May 11th, 2020
- Highlights and Business Update
- Financial Performance Q1 2020
Today's presenters
- Outlook 2020
- Q&A
Dr. Joachim Kuhn (CEO) Stefan Döhmen (CFO)
- CoVid-19 Impact mostly relevant in business line "Products"
- Systems and Services with slight tailwind (Healthcare logistics)
- Supply chain stable – no business interruptions
- Production and service continued
- No positive tested cases currently @ VQT
- TempChain Service Network up and running
- All customer orders could be fulfilled
- No worktime reduction
Growth continues despite CoVid-19
Good growth performance Revenue +15% to 17.6 Mio. EUR (Q1 2019: 15.2)
Systems revenue up 92% YOY to 4.8 Mio. EUR
(Q1 2019: 2.5 Mio. EUR)
EBITDA +27% to 2.8 Mio. EUR (Q1 2019: 2.2)
Healthcare & Logistics with >70% Revenue share
(Q1 2019: 59%)
5
Group revenues grew by 15%, Healthcare & Logistics with 73% Revenue share
In EUR Mio.
Q1 2020: 17.6 Mio. EUR
Strong growth fuelled by Services and Systems, "Products" with CoVid-19 impact
Strong EBITDA increase by 27% YOY
Cash Flow Summary: Strong operational CF development
| in EUR Mio. | Q1 20 | Q1 19 |
|---|---|---|
| Operating cash flow before changes in Working Capital |
2.0 | 0.5 |
| Operating cash flow | 1.5 | -0.9 |
| Investing cash flow |
-2.1 | -1.3 |
| thereof payments for investments in property, plant and equipment |
-1.8 | -1.4 |
| Financing cash flow |
2.3 | -2.0 |
| Net change in cash | 1.6 | -4.3 |
| Free Cash flow | -0.6 | -2.2 |
Comments
- Operating CF before and after WC positive, clear upward trend
- Investing CF on low level, similar to Q1 2019
- Free CF still slightly negative, but approaching the zero line
- Cash position of 9.2 Mio. EUR at the end of Q1 2020
Solid equity ratio of 39%, no goodwill
Outlook 2020 confirmed
FY 2019 FY 2020 Outlook incl. possible CoVid-19 effects FY 2020 Outlook excl. CoVid-19 effects 64,7 Mio EUR +28% Moderate to medium growth Medium to strong revenue growth 13% on Total income, 15% on Revenue Stable margin Margin increase Revenue EBITDA
Our portfolio plays a significant role along the entire COVID-19 healthcare logistics
Currently >50% of all intl. transported testkits use VQT solutions
Temperature – Time – Testified Precision
Thank you for your attention!
va-Q-tec AG
Alfred-Nobel-Straße 33 97080 Würzburg Tel.: +49 931 35942-1616 Fax: +49 931 35942-0 [email protected]
TICKER
Symbol: VQT Bloomberg: VQT:GY Reuters: VQTG:DE ISIN: DE0006636681 WKN: 663668
15